Summary by Futu AI
PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (STOCK CODE: 2269), I.E. WUXI BIO, ANNOUNCED ON MARCH 31, 2024 ITS LIST OF BOARD MEMBERS, INCLUDING EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTORS AND INDEPENDENT NON-EXECUTIVE DIRECTORS. THE CEO OF THE COMPANY IS DR. CHAN CHI SHENG AND THE CHAIRMAN IS DR. LI KEG. In addition, there are five committees under the Board of Directors, including the Audit Committee, the Remuneration Committee, the Nominating Committee, the Decision Committee and the Environment, Social and Governance Committees, with a clear list of the chairmen and members of each committee. The announcement demonstrates the transparency of the company's governance structure and provides investors with updates on the company's leadership.